よむ、つかう、まなぶ。
【参考資料4】抗微生物薬適正使用の手引き 第三版 本編 (102 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
| 出典情報 | 厚生科学審議会 感染症部会 薬剤耐性（AMR）に関する小委員会 抗微生物薬適正使用（AMS）等に関する作業部会（第6回 11／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第三版
66. Little P, et al. Antibiotics for lower respiratory tract infection in children presenting in primary
care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet.
2021 Oct 16;398(10309):1417-1426.
67. Hersh AL, Jackson MA, Hicks LA. Principles of judicious antibiotic prescribing for upper
respiratory tract infections in pediatrics. Pediatrics. Dec 2013;132(6):1146-1154.
68. National Institute for Health and Care Excellence (NICE). National Institute for Health and
Clinical Excellence (NICE) guidance on prescribing of antibiotics for self-limiting respiratory
tract infections in adults and children in primary care. 2008.
69. Gibson PG, Chang AB, Glasgow NJ, et al. CICADA: Cough in Children and Adults: Diagnosis
and Assessment. Australian cough guidelines summary statement. The Medical journal of
Australia. Mar 01 2010;192(5):265-271.
70. Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice
guidelines. Chest. Jan 2006;129(1 Suppl):95s-103s.
71. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory
tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst
Rev. Jan 08 2015;1:Cd004875.
72. Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of
Pertussis: 2005 CDC Guidelines
73. Ruffles TJC, et al. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in
children (DACS): a multi-centre, double blind, randomised controlled trial. Lancet Respir
Med. 2021 Oct;9(10):1121-1129.
74. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis,
management, and prevention of bronchiolitis. Pediatrics. Nov 2014; 134(5):e1474-1502.
75. Haskell L, Tavender EJ, Wilson CL, O'Brien S, Babl FE, Borland ML, Cotterell E, Schembri
R, Orsini F, Sheridan N, Johnson DW, Oakley E, Dalziel SR; PREDICT Network.
Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis: A
Randomized Clinical Trial. JAMA Pediatr. 2021 Aug 1;175(8):797-806.
76. Schreiber S, Ronfani L, Ghirardo S, et al. Nasal irrigation with saline solution significantly
improves oxygen saturation in infants with bronchiolitis. Acta paediatrica 2016;105:292-6.
77. Farley R, Spurling GK, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under
two years of age. Cochrane Database Syst Rev. Oct 09 2014(10):Cd005189.
78. Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial
infection in children hospitalized with bronchiolitis. Hospital pediatrics 2014; 4:33-8.
79. Tomochika K, Ichiyama T, Shimogori H, Sugahara K, Yamashita H, Furukawa S. Clinical
characteristics of respiratory syncytial virus infection-associated acute otitis media. Pediatrics
international: official journal of the Japan Pediatric Society. Aug 2009; 51(4):484-487.
80. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children
with bronchiolitis. Pediatrics. Apr 1998; 101(4 Pt 1):617-619.
81. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in
infants and young children. Cochrane Database Syst Rev. Jun 04 2013(6):Cd004878.
82. Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database
Syst Rev. Jun 15 2011(6):Cd003123.
102
第三版
66. Little P, et al. Antibiotics for lower respiratory tract infection in children presenting in primary
care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet.
2021 Oct 16;398(10309):1417-1426.
67. Hersh AL, Jackson MA, Hicks LA. Principles of judicious antibiotic prescribing for upper
respiratory tract infections in pediatrics. Pediatrics. Dec 2013;132(6):1146-1154.
68. National Institute for Health and Care Excellence (NICE). National Institute for Health and
Clinical Excellence (NICE) guidance on prescribing of antibiotics for self-limiting respiratory
tract infections in adults and children in primary care. 2008.
69. Gibson PG, Chang AB, Glasgow NJ, et al. CICADA: Cough in Children and Adults: Diagnosis
and Assessment. Australian cough guidelines summary statement. The Medical journal of
Australia. Mar 01 2010;192(5):265-271.
70. Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice
guidelines. Chest. Jan 2006;129(1 Suppl):95s-103s.
71. Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory
tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst
Rev. Jan 08 2015;1:Cd004875.
72. Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of
Pertussis: 2005 CDC Guidelines
73. Ruffles TJC, et al. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in
children (DACS): a multi-centre, double blind, randomised controlled trial. Lancet Respir
Med. 2021 Oct;9(10):1121-1129.
74. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis,
management, and prevention of bronchiolitis. Pediatrics. Nov 2014; 134(5):e1474-1502.
75. Haskell L, Tavender EJ, Wilson CL, O'Brien S, Babl FE, Borland ML, Cotterell E, Schembri
R, Orsini F, Sheridan N, Johnson DW, Oakley E, Dalziel SR; PREDICT Network.
Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis: A
Randomized Clinical Trial. JAMA Pediatr. 2021 Aug 1;175(8):797-806.
76. Schreiber S, Ronfani L, Ghirardo S, et al. Nasal irrigation with saline solution significantly
improves oxygen saturation in infants with bronchiolitis. Acta paediatrica 2016;105:292-6.
77. Farley R, Spurling GK, Eriksson L, Del Mar CB. Antibiotics for bronchiolitis in children under
two years of age. Cochrane Database Syst Rev. Oct 09 2014(10):Cd005189.
78. Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial
infection in children hospitalized with bronchiolitis. Hospital pediatrics 2014; 4:33-8.
79. Tomochika K, Ichiyama T, Shimogori H, Sugahara K, Yamashita H, Furukawa S. Clinical
characteristics of respiratory syncytial virus infection-associated acute otitis media. Pediatrics
international: official journal of the Japan Pediatric Society. Aug 2009; 51(4):484-487.
80. Andrade MA, Hoberman A, Glustein J, Paradise JL, Wald ER. Acute otitis media in children
with bronchiolitis. Pediatrics. Apr 1998; 101(4 Pt 1):617-619.
81. Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in
infants and young children. Cochrane Database Syst Rev. Jun 04 2013(6):Cd004878.
82. Hartling L, Bialy LM, Vandermeer B, et al. Epinephrine for bronchiolitis. Cochrane Database
Syst Rev. Jun 15 2011(6):Cd003123.
102